
ãããã®æçšåæ°ãå°ãªãæ¹ã飲ã¿å¿ãã¯å°ãªãã®ãïŒãäºæ³å€ã®çµæãã
ããããã飲ããšãã«æçšåæ°ãå°ãªãã»ã©é£²ã¿å¿ãã¯å°ãªãã ããã
ãã£ãšããæã£ãŠããŸãããã
ã»ããšãã«ãããªãã ãããïŒ
ãšããçåãæ¹§ããŸããã
ããã¶ãã£ãã©ãŒãSR200mgãæå€é£åŸã
æã®è¬ã¯é£²ããŸãããå€ã®è¬ã飲ã¿å¿ããããšãå€ãããé£²ã¿æ®ããå¢ããïŒåã»ã©æ®è¬èª¿æŽãç¶ããæ¹ãããŸããã
ãã£ãã©ãŒãç³»ã®è¬å€ã ãšä»ã«ã
âãã§ããã£ãã©ãŒãïŒãªããã£ã«Â®ïŒ
âãããã£ãã©ãŒãïŒãã«ã¢ãã£ã¢Â®ïŒ
ããããŸãã
æçšåæ°ã§ã¿ããš
ãïŒïŒæ¥ïŒåïŒ
ãã¶ãã£ãã©ãŒãããããã£ãã©ãŒã
ãïŒïŒæ¥ïŒåïŒ
ãã§ããã£ãã©ãŒã
ãšãªã£ãŠããŠãæçšåæ°ãæžããã«ã¯ãã§ããã£ãã©ãŒããžã®åãæ¿ããšããéžæè¢ããããŸãã
ãªã®ã§ããïŒæ¥ïŒåã«ããã飲ã¿å¿ããæžãã ããïŒããšããæµãã§ãã
ãã¶ãã£ãã©ãŒããšãã§ããã£ãã©ãŒãã®å¹æã®å·®ã¯ïŒ
ãŸãã¯æçšåæ°ã®åã«ãããããè¬ãåãæ¿ããŠãåã广ãåŸãããã®ãã©ããïŒãšããéšåã倧åã«ãªãã®ã§èŠãŠãããŸãã
ãè¬ã䟡ã
ãã§ããã£ãã©ãŒã53.3mgïŒ12.0å
ãã§ããã£ãã©ãŒã80mgïŒ15.9å
ïŒ1æ¥24åïœ31.8åïŒ
ãã¶ãã£ãã©ãŒãSR200mgïŒ10.1å
ïŒïŒæ¥20.2åïŒ
â ãã¶ãã£ãã©ãŒãïŒ400mg/æ¥ïŒ
ã»PPARαã»ÎŽã»Î³ã«äœçš
ïŒïŒ11 ïœ 19ïŒ ãLDLïŒïŒ£ïŒïŒ12 ïœ21ïŒ
ïŒïŒ30 ïœ 57ïŒ ãHDLïŒïŒ£ïŒïŒ32 ïœ 48ïŒ
â ãã§ããã£ãã©ãŒãïŒ106.6mgïœ160mg/æ¥ïŒ
ã»PPARαã®ã¿ã«äœçš
ã»å°¿é žäœäžäœçšãã
TC -17%,TG -48%,HDL-C +36%
ïŒïŒ9ïœ22ïŒ ãLDL-ïŒïŒ17ïœ29ïŒ
ïŒïŒ33ïœ54ïŒ ãHDL-ïŒïŒ25ïœ67ïŒ
ããããããã
ïŒã€ã³ã¿ãã¥ãŒãã©ãŒã ããæç²ïŒ
è¬ã®äŸ¡æ ŒãšããŠããã³ã¬ã¹ãããŒã«äœäžäœçšãšããŠãããã»ã©å·®ããããããªæãã¯ãããŸããã
äž¡å€ã®èšåºã§ã®å¹æãæ¯èŒããå ±åããããŸãã
â 察象ïŒ
61äŸïŒç·æ§43äŸã女æ§18äŸïŒ
â æ¹æ³ïŒ
ãã§ããã£ãã©ãŒãããã¶ãã£ãã©ãŒãã«åãæ¿ãã
â çµæïŒ
åãæ¿ã20é±åŸã®è質(LDL-C, TG, HDL-C)ããã³ç³ä»£è¬(HbA1c)ã«å¯Ÿããå®å
šæ§ãšå¹æãè©äŸ¡
ããã¶ãã£ãã©ãŒããžã®åãæ¿ãåŸãè¡æž LDL-Cå€ãTGå€ã«ææãªå€åã¯èªããããªãã£ãããåãæ¿ãåŸ20é±ç®ã«ã¯è¡æž HDL-Cå€ã49.5±1.7mg/dLãã52.5±2.0mg/dLãžãšææãªäžæãèªããããããŸããHbA1cå€ã¯5.92±0.34ïŒ ãã5.72±0.33ïŒ ãžãšææã«äœäžããã
ãã®äžã§ã¯ã°ã«ã³ãŒã¹ä»£è¬ãšïŒšïŒ€ïŒ¬ïŒïŒ£å€ã«ã€ããŠãã¶ãã£ãã©ãŒãã®æ¹ãè¯å¥œãªæ°å€ã瀺ãããšãããã®ã§ãã
ïŒåèè³æïŒ
ãã£ãã©ãŒãç³»è¬å€ã®åæ¿ãã«ããè質代è¬ïŒç³ä»£è¬æ¹åå¹æã®æ¯èŒæ€èš-ãã¶ãã£ãã©ãŒããšãã§ããã£ãã©ãŒãã®å®èšåºã§ã®çžéã«ã€ããŠ-.Therapeutic Research,33(10):1561-1568,2012
ãããŸã§ã®å¹æãæåŸ ããŠäœ¿çšããŠãããšãæããªããããïŒæ¥ïŒåã®ãã§ããã£ãã©ãŒããžã®åãæ¿ãã§ïŒ¯ïŒ«ãšä»®å®ããŠãããŸãã
æçšåæ°ã«ã€ããŠ
æçšåæ°ã«çãçµã£ãŠããã€ãæç®ã®å 容ãããã¯ã¢ããããŠã¿ãããšæããŸãã
ãæçšåæ°ã«é¢ããŠã1æ¥ã®æçšåæ°ã®å¢æžã«ããã³ã³ãã©ã€ã¢ã³ã¹ã®å²åãç¹å¥ã®åŸåã瀺ãããšã¯ãªãã£ããšããå ±å¹âŸããããŸãã
æè¬éµå®çïŒã³ã³ãã©ã€ã¢ã³ã¹ïŒ
1åã41.4ïŒ ïŒ12/29ïŒ
2åã47.1ïŒ ïŒ41/87ïŒ
3åã36.8ïŒ ïŒ160/435ïŒ
4åã46.2ïŒ ïŒ30/65ïŒ
ããŸããæ£è ã®åžæããæçšåæ°ãšããŠãã1 æ¥ 1ïœ3 åã§å€§ããªå·®ãã¿ãããªãã£ããšããå ±å²âŸããããŸãã
1å430ä»¶ã2å300ä»¶ã3åã450ä»¶ãããã
ãæ®è¬ç®¡çã®æè¬ã¢ããã¢ã©ã³ã¹ã«äžãã圱é¿ãã¿ãå ±å³âŸã§ã¯ãæ®è¬ã®å èš³ã«ã€ããŠèª¿ã¹ãŠããŸãã
ããæ®è¬ã®å
èš³ãã
çšæ³å¥ã®åç®æ°ã§ã¯ã1æ¥1åã130åç®ïŒ30.9ïŒ
ïŒã1 æ¥ 2 åã 69 åç®ïŒ16.4ïŒ
ïŒã1 æ¥ 3 åã 159 åç®ïŒ37.8ïŒ
ïŒãšã1 æ¥ 1 åãš 3 åã®å»è¬åãå€ããªã£ãŠããŸãã
çšæ³å¥ã«é¢ããŠã¯ïŒè¬å€æ°ã§ã¯ 1 æ¥ 3 åã®å»è¬åãéåæ°ãå ãïŒç¹ã«æŒã®è¬ã®é£²ã¿æ®ããå€ãã£ããšãããŠããŸããïŒæ¥ïŒåããŸãæå€ã«ãæ¯èŒçé£²ã¿æ®ããå€ããªã£ãŠããŸãã
ãããŸã§ã®çµæãã¿ããšãæçšåæ°ã«ãã£ãŠé£²ã¿å¿ããæžããïŒãšèšããããšã¯ã£ããæèšã¯ã§ããŸããããïŒæ¥ïŒåããã¯ãïŒæ¥ïŒåãïŒæ¥ïŒåã®æ¹ã飲ã¿å¿ãã¯å°ãªããã ãªãšããçµæã¯ã§ãŠãããšæããŸãã
ãŸãã1æ¥ ã®æçšåæ°ãå°ãªãæ¹ã飲ã¿å¿ããæžå°ãããããªæ°ãããŸããããã®ãããªå ±åãèŠãããŸãâŽâŸã
ããäžã€ãïŒæ¥ïŒåã§æçšããå Žåã«ãã©ã®æç¹ã§ã®é£²ã¿å¿ããå€ãã調ã¹ããã®âµâŸã
æè¬æå»å¥ã§ã¯ã飲ã¿å¿ãã®å²åãæ (9%)ãå€ (8%)ãç å (6%) ã«æ¯ã¹ãŠ, æŒ (21%)ãæãé«ãå²åã§ããã
ïŒãæŒãïŒãæãïŒãå€ãïŒãå¯ãåãïŒ
æŒã®è¬ã飲ã¿å¿ããçç±ãšããŠã¯
â è·å Žãå€åºæã«ãããè¬ã®äžæºåž¯
â¡åãªã飲ã¿å¿ã
â¢é£äºãæããªãããšã«ããè¬ã®èªå·±äžæ
ãªã©ãèããããŸãã
ãã®ä»é£²ã¿å¿ãã®çç±ãšããŠã¯ããã€ããããŸããã
âãã£ããããŠå¿ãã
âå¿ãããŠå¿ãã
âç
æ°ãæ²»ã£ããšæã£ã
âå¯äœçšãå¿é
âæå
ã«ãªãã£ã
âè¬ã®çš®é¡ãå€ã
âæè¬åæ°ãå€ã
âé£äºããšããªãã£ã
âãé
ã飲ãã
ãªã©ãæããããŠããŸãâ¶âŸã
ïŒåèè³æïŒ
ïŒïŒã³ã³ãã©ã€ã¢ã³ã¹ã«åœ±é¿ãäžããèŠå .ç é¢è¬åŠ,11(3):276-283,1985
ïŒïŒæè¬ã³ã³ãã©ã€ã¢ã³ã¹ã®ãããªãåäžãšè¬å€ç®¡çæå°æ¥å.å»çè¬åŠ,34(8):800-804,2008
ïŒïŒç¯è¬ããã°ã掻çšããæ®è¬ç®¡çã®æè¬ã¢ããã¢ã©ã³ã¹ã«äžãã圱é¿.å»çè¬åŠ,43(6) 344-350,2017
ïŒïŒæ£è ã®æè¬æå°.è¬å±,32:813-820,1981
ïŒïŒè幎æ£è ã®æè¬ã³ã³ãã©ã€ã¢ã³ã¹.æ¥æ¬è幎å»åŠäŒéèª,29(11),1992
ïŒïŒæ¥æ¬å ç§åŠäŒéèª ç¬¬81å·» 第9å·ïŒå¹³æ4幎9æ10æ¥ïŒ
ãããã«
æè¬ã¢ããã¢ã©ã³ã¹ã«åœ±é¿ãåãŒãæ£è ã®æè調æ».å»çè¬åŠ,38(8) 522â533 (2012)
ããã®è³æã®äžã§ã¯ã飲ã¿å¿ãã«åœ±é¿ãåãŒãèŠå ã«ã€ããŠæ€èšããŠããŸãã
ãåæã«ãã£ãŠãæ¹å床ãé«ãïŒæ¹åããå¿
èŠãããïŒèšåãããã¯ã¢ããããŠããŸãã
ïŒ
ïŒïŒé£äºã¯èŠåæ£ãããšããŠãã
ïŒïŒç掻ãªãºã ã¯ãã¡ããšããŠãã
ïŒïŒè¬å€åž«ãä¿¡é ŒããŠãã
ïŒïŒãè¬ã®èª¬ææžã掻çšããŠãã
ïŒïŒè¬ã飲ã¿å¿ããªãããã«æ°ãã€ããŠãã
è¬ã®å¹æãèªèãã飲ã¿å¿ããæèããªããèŠåæ£ããçæŽ»ãéãããšã§ã飲ã¿å¿ããæžããããšãã§ãããšããçµè«ã§ãã
ãã®ããã«æçšåæ°ä»¥å€ã«ãæ§ã ãªèŠå ãé¢äžããŠããããããŸãã¯æ£è ããã®çæŽ»èæ¯ã®èãåããè¡ã£ãããã§ãæçšåæ°ã®æ¹åã«åãçµãããšã倧åã ãšæããŸãã
